Skip to main content

Business

HIMSS24
By HIMSS TV | 07:00 am | April 30, 2024
Dr. Jonah Feldman, medical director, clinical transformation and informatics at NYU Langone Health System, discusses an upcoming pilot study using AI to generate after-visit notes that are easier for patients to read and understand.  
By Adam Ang | 05:36 am | April 30, 2024
It is envisioned to cover greater distances, serving Australia's rural and remote communities, while being sustainable.
HIMSS24
By HIMSS TV | 05:57 pm | April 29, 2024
Gabriel Garcia-Lopez, health information systems director, Los Angeles LGBT Center, and 2024 Changemaker Award winner, discusses customizing digital intake systems to allow LGBTQ+ patients to enter SOGI (sexual orientation and gender identity) data.
By Trevor Dermody | 04:46 pm | April 29, 2024
The telemedicine giant reported a net loss of $81.9 million in the first quarter of the year and a 20% increase in EBITDA year-over-year. 
By Trevor Dermody | 06:00 pm | April 26, 2024
The startup plans to use the funds to build out its technology platform.
By Trevor Dermody | 09:55 am | April 25, 2024
The ODU-led team will assess the commercial viability and feasibility of digital environments for people who are visually impaired.
HIMSS24
By HIMSS TV | 07:00 am | April 25, 2024
Rachelle Landry, VP of clinical transformation at BD, discusses how interoperability, robotics and AI enable care delivery outside traditional settings, but must always be driven by clinicians' critical thinking and their connections to patients.  
HIMSS24
By HIMSS TV | 05:36 pm | April 24, 2024
Heidi Wold, chief population health officer, Longevity Health Plan, addresses biases in elder care, particularly the idea that seniors aren't interested in using technology, and talks about how nursing facilities can enhance seniors' quality of life.
By Jessica Hagen | 04:47 pm | April 24, 2024
The Series B funding round comes less than a year after the company closed a $25 million Series A round led by Google Ventures.
By Jessica Hagen | 03:21 pm | April 24, 2024
Xaira's CEO, Dr. Marc Tessier-Lavigne, resigned as president of Stanford University last August due to controversy over inaccuracies discovered in his lab's scientific papers.